31-Dec-2025
No headlines found.
Colony Bankcorp, Inc. Announces Christi Rubio as Chief of Brand and Business Development
Business Wire (Thu, 11-Dec 9:00 AM ET)
Colony Bank Named One of American Banker's Best Banks to Work for in 2025
Business Wire (Tue, 9-Dec 8:30 AM ET)
Colony Bankcorp, Inc. Announces Completion of Merger With TC Bancshares, Inc.
Business Wire (Mon, 1-Dec 8:30 AM ET)
Business Wire (Mon, 17-Nov 8:30 AM ET)
Colony Bankcorp Reports Third Quarter 2025 Results
Business Wire (Wed, 22-Oct 4:30 PM ET)
Colony Bankcorp, Inc. Announces Date for Third Quarter 2025 Earnings Release and Conference Call
Business Wire (Mon, 6-Oct 8:30 AM ET)
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
Colony Bankcorp trades on the NYSE stock market under the symbol CBAN.
As of December 31, 2025, CBAN stock price declined to $17.82 with 72,788 million shares trading.
CBAN has a beta of 0.79, meaning it tends to be less sensitive to market movements. CBAN has a correlation of 0.27 to the broad based SPY ETF.
CBAN has a market cap of $379.11 million. This is considered a Small Cap stock.
Last quarter Colony Bankcorp reported $33 million in Revenue and $.47 earnings per share. This fell short of revenue expectation by $-910,000 and exceeded earnings estimates by $.02.
In the last 3 years, CBAN traded as high as $18.80 and as low as $8.59.
The top ETF exchange traded funds that CBAN belongs to (by Net Assets): VTI, IWM, AVUV, VXF, IWN.
CBAN has underperformed the market in the last year with a price return of +12.4% while the SPY ETF gained +17.2%. However, in the short term, CBAN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +5.4% vs +2.7% return in SPY. But in the last 2 weeks, CBAN shares have been beat by the market, returning -3.2% compared to an SPY return of +0.7%.
CBAN support price is $17.61 and resistance is $18.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBAN shares will trade within this expected range on the day.
